Dohyun Deo investigated the impact of serum and intrahepatic hepatitis B virus markers on clinical outcomes in HBV-infected and OBI patients in The Gambian population.
@ProlificaA@gndow@maud_lemoine#COLDA2024
Take Action to eliminate #HepatitisB in Africa. - Get tested today
- Request a hepatitis B birth dose vaccine 💉 for your baby
- And end discrimination against people living with #HepatitisB#WorldHepatitisDay
https://t.co/b1GTnH8MMP
Is global elimination of hepatitis B really achievable?
« Whether hepatitis B elimination will be achieved in an equitable manner and in a reasonable timeframe remains highly uncertain ».
See our review in JVH
@maud_lemoine@ProlificaA@mrcunitgambia
https://t.co/j98I2TUoCA
Our review on «’Unusual’ HCV genotypes subtypes: origin, distribution, sensitivity to direct-acting drugs and behaviour on antiviral treatment and retreatment » is online @Gut_BMJ@JMPawlotsky
https://t.co/IsnYYbrC2v
Our HBV app for Africa is out!
Available on iOS & android
For providers seeing HBV in Africa that are not experts
Info on treatment, FU, vaccination, pregnancy, community education, etc
Please share with those in the field!
https://t.co/RWtPD2sOEJ
Our HBV app for Africa is out!
Available on iOS & android
For providers seeing HBV in Africa that are not experts
Info on treatment, FU, vaccination, pregnancy, community education, etc
Please share with those in the field!
https://t.co/RWtPD2sgPb
@GlobalHep@HepBFoundation
🚨Job Alert : Associate Professor or Professor of Immunology
📍The Gambia
Join our immunology research team and explore infant immune development and clinical trials!
Apply Now ➡️https://t.co/fqNokWkEAk
Dr @ErwanVoQuang shares results on virological characteristics of HCV treatment failures and outcomes of retreatment in people with “Unusual” HCV Genotype 1 Subtypes #COLDA2023 Read the full article here https://t.co/M54uReiO9I